ORPHAZYME A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 988.3 DKK | -8.81% |
|
-9.69% | -25.69% |
| Mar. 27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 1,224.40 | 1,400.00 | 2,905.00 |
| Spread/Res. | -19.28% | -29.41% | -65.98% |
| Spread/Supp. | -1.66% | +46.03% | +41.19% |
| Support | 1,005.00 | 676.80 | 700.00 |
- Stock Market
- Equities
- ORPHA Stock
- Charts Orphazyme A/S
